Separation of μ-Opioid Receptor Desensitization and Internalization: Endogenous Receptors in Primary Neuronal Cultures
A close relationship between desensitization and internalization of μ-opioid receptors (MORs) has been proposed based on differential actions of series of agonists. The role that these two processes have in the development of tolerance and dependence to opioids has been a controversial subject that...
Saved in:
Published in | The Journal of neuroscience Vol. 26; no. 15; pp. 4118 - 4125 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Society for Neuroscience
12.04.2006
|
Subjects | |
Online Access | Get full text |
ISSN | 0270-6474 1529-2401 1529-2401 |
DOI | 10.1523/JNEUROSCI.0303-06.2006 |
Cover
Abstract | A close relationship between desensitization and internalization of μ-opioid receptors (MORs) has been proposed based on differential actions of series of agonists. The role that these two processes have in the development of tolerance and dependence to opioids has been a controversial subject that has been studied in a variety of model systems. Here, we examine desensitization and internalization of endogenous MORs simultaneously in primary cultures of locus ceruleus neurons using fluorescently tagged peptide agonists. With the use of two fluorescent opioid peptides, dermorphin-Bodipy Texas Red and dermorphin-Alexa594 (Derm-A594), desensitization was measured electrophysiologically and trafficking was followed by the accumulation of intracellular fluorescent puncta. Blocking endocytosis with concanavalin A eliminated the accumulation of fluorescent puncta but desensitization induced by Derm-A594 was unaffected. Likewise, after treatment with concanavalin A, there was no change in either desensitization or recovery from desensitization induced by [Met]
5
enkephalin. The results demonstrate that desensitization and the recovery from desensitization are not dependent on receptor internalization and suggest that the activity of endogenous MORs in primary neurons can be modulated at the level of the plasma membrane. |
---|---|
AbstractList | A close relationship between desensitization and internalization of mu-opioid receptors (MORs) has been proposed based on differential actions of series of agonists. The role that these two processes have in the development of tolerance and dependence to opioids has been a controversial subject that has been studied in a variety of model systems. Here, we examine desensitization and internalization of endogenous MORs simultaneously in primary cultures of locus ceruleus neurons using fluorescently tagged peptide agonists. With the use of two fluorescent opioid peptides, dermorphin-Bodipy Texas Red and dermorphin-Alexa594 (Derm-A594), desensitization was measured electrophysiologically and trafficking was followed by the accumulation of intracellular fluorescent puncta. Blocking endocytosis with concanavalin A eliminated the accumulation of fluorescent puncta but desensitization induced by Derm-A594 was unaffected. Likewise, after treatment with concanavalin A, there was no change in either desensitization or recovery from desensitization induced by [Met]5enkephalin. The results demonstrate that desensitization and the recovery from desensitization are not dependent on receptor internalization and suggest that the activity of endogenous MORs in primary neurons can be modulated at the level of the plasma membrane. A close relationship between desensitization and internalization of mu-opioid receptors (MORs) has been proposed based on differential actions of series of agonists. The role that these two processes have in the development of tolerance and dependence to opioids has been a controversial subject that has been studied in a variety of model systems. Here, we examine desensitization and internalization of endogenous MORs simultaneously in primary cultures of locus ceruleus neurons using fluorescently tagged peptide agonists. With the use of two fluorescent opioid peptides, dermorphin-Bodipy Texas Red and dermorphin-Alexa594 (Derm-A594), desensitization was measured electrophysiologically and trafficking was followed by the accumulation of intracellular fluorescent puncta. Blocking endocytosis with concanavalin A eliminated the accumulation of fluorescent puncta but desensitization induced by Derm-A594 was unaffected. Likewise, after treatment with concanavalin A, there was no change in either desensitization or recovery from desensitization induced by [Met]5enkephalin. The results demonstrate that desensitization and the recovery from desensitization are not dependent on receptor internalization and suggest that the activity of endogenous MORs in primary neurons can be modulated at the level of the plasma membrane.A close relationship between desensitization and internalization of mu-opioid receptors (MORs) has been proposed based on differential actions of series of agonists. The role that these two processes have in the development of tolerance and dependence to opioids has been a controversial subject that has been studied in a variety of model systems. Here, we examine desensitization and internalization of endogenous MORs simultaneously in primary cultures of locus ceruleus neurons using fluorescently tagged peptide agonists. With the use of two fluorescent opioid peptides, dermorphin-Bodipy Texas Red and dermorphin-Alexa594 (Derm-A594), desensitization was measured electrophysiologically and trafficking was followed by the accumulation of intracellular fluorescent puncta. Blocking endocytosis with concanavalin A eliminated the accumulation of fluorescent puncta but desensitization induced by Derm-A594 was unaffected. Likewise, after treatment with concanavalin A, there was no change in either desensitization or recovery from desensitization induced by [Met]5enkephalin. The results demonstrate that desensitization and the recovery from desensitization are not dependent on receptor internalization and suggest that the activity of endogenous MORs in primary neurons can be modulated at the level of the plasma membrane. A close relationship between desensitization and internalization of μ-opioid receptors (MORs) has been proposed based on differential actions of series of agonists. The role that these two processes have in the development of tolerance and dependence to opioids has been a controversial subject that has been studied in a variety of model systems. Here, we examine desensitization and internalization of endogenous MORs simultaneously in primary cultures of locus ceruleus neurons using fluorescently tagged peptide agonists. With the use of two fluorescent opioid peptides, dermorphin-Bodipy Texas Red and dermorphin-Alexa594 (Derm-A594), desensitization was measured electrophysiologically and trafficking was followed by the accumulation of intracellular fluorescent puncta. Blocking endocytosis with concanavalin A eliminated the accumulation of fluorescent puncta but desensitization induced by Derm-A594 was unaffected. Likewise, after treatment with concanavalin A, there was no change in either desensitization or recovery from desensitization induced by [Met] 5 enkephalin. The results demonstrate that desensitization and the recovery from desensitization are not dependent on receptor internalization and suggest that the activity of endogenous MORs in primary neurons can be modulated at the level of the plasma membrane. A close relationship between desensitization and internalization of mu -opioid receptors (MORs) has been proposed based on differential actions of series of agonists. The role that these two processes have in the development of tolerance and dependence to opioids has been a controversial subject that has been studied in a variety of model systems. Here, we examine desensitization and internalization of endogenous MORs simultaneously in primary cultures of locus coeruleus neurons using fluorescently tagged peptide agonists. With the use of two fluorescent opioid peptides, dermorphin-Bodipy Texas Red and dermorphin-Alexa594 (Derm-A594), desensitization was measured electrophysiologically and trafficking was followed by the accumulation of intracellular fluorescent puncta. Blocking endocytosis with concanavalin A eliminated the accumulation of fluorescent puncta but desensitization induced by Derm-A594 was unaffected. Likewise, after treatment with concanavalin A, there was no change in either desensitization or recovery from desensitization induced by [Met] super(5)enkephalin. The results demonstrate that desensitization and the recovery from desensitization are not dependent on receptor internalization and suggest that the activity of endogenous MORs in primary neurons can be modulated at the level of the plasma membrane. |
Author | Torrecilla, Maria Kobayashi, Kazuto Arttamangkul, Seksiri Williams, John T. Okano, Hideyuki |
Author_xml | – sequence: 1 givenname: Seksiri surname: Arttamangkul fullname: Arttamangkul, Seksiri – sequence: 2 givenname: Maria surname: Torrecilla fullname: Torrecilla, Maria – sequence: 3 givenname: Kazuto surname: Kobayashi fullname: Kobayashi, Kazuto – sequence: 4 givenname: Hideyuki surname: Okano fullname: Okano, Hideyuki – sequence: 5 givenname: John T. surname: Williams fullname: Williams, John T. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16611829$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUsFu1DAUtFAR3RZ-ofKJW7Z24tgxQkho2cJWVRe19Gw5yUsxytqp7VCVb-Mb-Cac7rICDnCy5DcznnmeI3RgnQWETiiZ0zIvTs8vlzdX6-vFak4KUmSEz3NC-BM0S1OZ5YzQAzQjuSAZZ4IdoqMQvhBCBKHiGTqknFNa5XKG7q9h0F5H4yx2Hf7xPVsPxpkWX0EDQ3Qev4MANphovm1R2rZ4ZSN4q_vd3Su8tK27BevGsCcGbCz-6M1G-wd8CaN3iYAXYx9HD-E5etrpPsCL3XmMbs6WnxYfsov1-9Xi7UXWMFbEjJXQ1pRTWRPe0q7utGZkSiypqOqc67xralHSQkpSsapsdJXrFLPTopWgi-IYvdnqDmO9gbYBG73u1bD1pZw26s-JNZ_VrfuqOBdFJUUSeLkT8O5uhBDVxoQG-l5bSHEVFxVnpWT_BVJB6eQ0AU9-t7T38utTEuD1FtB4F4KHTjUmPi46OTS9okRNHVD7DqhpI4pwNXUg0flf9P0L_yb-BPHUuoc |
CitedBy_id | crossref_primary_10_1038_bjp_2008_100 crossref_primary_10_1074_jbc_M807535200 crossref_primary_10_1074_jbc_M806588200 crossref_primary_10_1016_j_neuropharm_2007_06_005 crossref_primary_10_1016_j_vascn_2021_107132 crossref_primary_10_1111_j_1471_4159_2007_04812_x crossref_primary_10_1111_j_1476_5381_2011_01482_x crossref_primary_10_4161_cc_10_21_18042 crossref_primary_10_1523_JNEUROSCI_4749_08_2009 crossref_primary_10_1016_j_tips_2006_09_006 crossref_primary_10_1523_JNEUROSCI_1310_16_2016 crossref_primary_10_1016_j_peptides_2007_09_002 crossref_primary_10_1371_journal_pone_0250011 crossref_primary_10_1002_ar_20860 crossref_primary_10_1152_jn_00563_2012 crossref_primary_10_1016_j_neuron_2018_04_021 crossref_primary_10_1111_bph_12709 crossref_primary_10_7554_eLife_34989 crossref_primary_10_1016_j_neuron_2012_09_022 crossref_primary_10_1021_acs_jmedchem_5b01664 crossref_primary_10_1371_journal_pone_0110230 crossref_primary_10_1124_mol_113_089003 crossref_primary_10_1152_ajpcell_00443_2018 crossref_primary_10_3389_fncir_2014_00062 crossref_primary_10_1016_j_brainres_2008_06_035 crossref_primary_10_1111_j_1471_4159_2008_05764_x crossref_primary_10_1074_jbc_M806742200 crossref_primary_10_1523_JNEUROSCI_5999_10_2011 crossref_primary_10_1016_j_neuropharm_2015_04_033 crossref_primary_10_1124_mol_112_079350 crossref_primary_10_1016_j_neuron_2008_02_006 crossref_primary_10_1523_JNEUROSCI_1227_12_2012 crossref_primary_10_1111_bph_12706 crossref_primary_10_1111_bph_12703 crossref_primary_10_7554_eLife_68130 crossref_primary_10_1038_npp_2015_109 crossref_primary_10_1124_mol_112_078659 crossref_primary_10_1523_JNEUROSCI_1157_07_2007 crossref_primary_10_1124_jpet_106_113621 crossref_primary_10_1016_j_neuropharm_2022_109408 crossref_primary_10_1007_s10571_011_9755_5 crossref_primary_10_1016_j_neuroscience_2013_04_034 crossref_primary_10_1021_acs_jmedchem_7b01811 crossref_primary_10_1113_jphysiol_2014_275701 crossref_primary_10_1111_j_1476_5381_2011_01387_x crossref_primary_10_1124_pr_112_005942 crossref_primary_10_1111_bph_13901 crossref_primary_10_1016_j_neuroscience_2006_06_021 crossref_primary_10_1523_JNEUROSCI_4136_11_2011 crossref_primary_10_1186_1756_6606_4_25 crossref_primary_10_1371_journal_pone_0188607 crossref_primary_10_1124_jpet_110_172643 crossref_primary_10_1124_mol_111_076208 crossref_primary_10_1124_mol_119_119321 crossref_primary_10_1124_mol_108_048512 crossref_primary_10_1016_j_pnpbp_2019_02_010 crossref_primary_10_1124_mol_119_119362 crossref_primary_10_1124_mol_107_042952 crossref_primary_10_1146_annurev_physiol_042022_015914 crossref_primary_10_1158_0008_5472_CAN_06_3803 crossref_primary_10_1002_jnr_21653 crossref_primary_10_1016_j_neuroscience_2010_04_003 crossref_primary_10_1016_j_neuropharm_2015_04_013 |
Cites_doi | 10.1038/sj.bjp.0702693 10.1677/joe.1.05654 10.1016/S0896-6273(01)00517-7 10.1523/JNEUROSCI.22-13-05769.2002 10.1038/sj.bjp.0702922 10.1074/jbc.273.50.33174 10.1073/pnas.072075399 10.1038/sj.bjp.0705781 10.1016/S0026-895X(24)13072-6 10.1152/physrev.2001.81.1.299 10.1124/mol.105.013185 10.1523/JNEUROSCI.18-12-04588.1998 10.1523/JNEUROSCI.2499-04.2004 10.1124/mol.104.004994 10.1016/S0022-3565(24)38179-0 10.1523/JNEUROSCI.06-11-03229.1986 10.1074/jbc.M300525200 10.1074/jbc.M204136200 10.1124/mol.104.004747 10.1146/annurev.neuro.27.070203.144206 10.1210/me.2003-0066 10.1124/mol.58.6.1570 10.1016/S0031-6997(24)01478-9 10.1002/syn.10014 10.1016/S0959-4388(03)00069-2 10.1124/mol.52.1.136 10.1186/1475-925X-2-13 10.1124/jpet.102.040378 10.1016/0896-6273(94)90283-6 10.1124/mol.65.3.528 10.1523/JNEUROSCI.5045-04.2005 10.1046/j.1471-4159.2002.00972.x 10.1016/j.coph.2004.08.012 10.1074/jbc.271.32.19021 10.1073/pnas.111152398 10.1016/j.conb.2004.05.005 10.1523/JNEUROSCI.22-11-04328.2002 10.1016/S0896-6273(01)80032-5 |
ContentType | Journal Article |
Copyright | Copyright © 2006 Society for Neuroscience 0270-6474/06/264118-08$15.00/0 2006 |
Copyright_xml | – notice: Copyright © 2006 Society for Neuroscience 0270-6474/06/264118-08$15.00/0 2006 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 7X8 5PM |
DOI | 10.1523/JNEUROSCI.0303-06.2006 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1529-2401 |
EndPage | 4125 |
ExternalDocumentID | PMC6673897 16611829 10_1523_JNEUROSCI_0303_06_2006 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIDA NIH HHS grantid: T32 DA007262 – fundername: NIDA NIH HHS grantid: DA08163 – fundername: NIDA NIH HHS grantid: DA016627 |
GroupedDBID | --- -DZ -~X .55 .GJ 18M 1CY 2WC 34G 39C 3O- 53G 5GY 5RE 5VS AAFWJ AAJMC AAYXX ABBAR ABIVO ACGUR ACNCT ADBBV ADCOW ADHGD ADXHL AENEX AETEA AFCFT AFFNX AFOSN AFSQR AHWXS ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CITATION CS3 DIK DU5 E3Z EBS EJD F5P GX1 H13 HYE H~9 KQ8 L7B MVM OK1 P0W P2P QZG R.V RHI RIG RPM TFN TR2 W8F WH7 WOQ X7M XJT YBU YHG YKV YNH YSK AFHIN AIZTS CGR CUY CVF ECM EIF NPM RHF 7TK 7X8 5PM |
ID | FETCH-LOGICAL-c443t-45edb1619b06d1fbfaa4003039178b26a2fcb75139908485ca82a007fa7d9ea33 |
ISSN | 0270-6474 1529-2401 |
IngestDate | Thu Aug 21 14:12:43 EDT 2025 Fri Sep 05 11:06:40 EDT 2025 Thu Sep 04 18:35:58 EDT 2025 Wed Feb 19 02:35:01 EST 2025 Tue Jul 01 02:58:35 EDT 2025 Thu Apr 24 23:03:57 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 15 |
Language | English |
License | https://creativecommons.org/licenses/by-nc-sa/4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c443t-45edb1619b06d1fbfaa4003039178b26a2fcb75139908485ca82a007fa7d9ea33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jneurosci.org/content/jneuro/26/15/4118.full.pdf |
PMID | 16611829 |
PQID | 17117513 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6673897 proquest_miscellaneous_67864594 proquest_miscellaneous_17117513 pubmed_primary_16611829 crossref_citationtrail_10_1523_JNEUROSCI_0303_06_2006 crossref_primary_10_1523_JNEUROSCI_0303_06_2006 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2006-04-12 |
PublicationDateYYYYMMDD | 2006-04-12 |
PublicationDate_xml | – month: 04 year: 2006 text: 2006-04-12 day: 12 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of neuroscience |
PublicationTitleAlternate | J Neurosci |
PublicationYear | 2006 |
Publisher | Society for Neuroscience |
Publisher_xml | – name: Society for Neuroscience |
References | (2023041303174552000_26.15.4118.22) (1994); 12 (2023041303174552000_26.15.4118.38) (1984); 26 (2023041303174552000_26.15.4118.40) (2001); 81 2023041303174552000_26.15.4118.21 2023041303174552000_26.15.4118.41 2023041303174552000_26.15.4118.20 (2023041303174552000_26.15.4118.10) (1999); 127 2023041303174552000_26.15.4118.28 2023041303174552000_26.15.4118.3 2023041303174552000_26.15.4118.25 2023041303174552000_26.15.4118.4 2023041303174552000_26.15.4118.5 2023041303174552000_26.15.4118.23 2023041303174552000_26.15.4118.6 2023041303174552000_26.15.4118.24 2023041303174552000_26.15.4118.7 2023041303174552000_26.15.4118.8 2023041303174552000_26.15.4118.9 (2023041303174552000_26.15.4118.34) (1998); 18 (2023041303174552000_26.15.4118.39) (1987); 243 (2023041303174552000_26.15.4118.26) (1998); 54 (2023041303174552000_26.15.4118.2) (2000); 58 (2023041303174552000_26.15.4118.35) (2002); 22 (2023041303174552000_26.15.4118.1) (2002); 22 2023041303174552000_26.15.4118.32 2023041303174552000_26.15.4118.11 2023041303174552000_26.15.4118.33 2023041303174552000_26.15.4118.30 2023041303174552000_26.15.4118.18 2023041303174552000_26.15.4118.19 (2023041303174552000_26.15.4118.27) (1999); 289 2023041303174552000_26.15.4118.17 2023041303174552000_26.15.4118.14 (2023041303174552000_26.15.4118.29) (1986); 6 2023041303174552000_26.15.4118.36 2023041303174552000_26.15.4118.15 (2023041303174552000_26.15.4118.31) (1995); 47 2023041303174552000_26.15.4118.37 2023041303174552000_26.15.4118.12 2023041303174552000_26.15.4118.13 (2023041303174552000_26.15.4118.16) (2001); 53 |
References_xml | – volume: 127 start-page: 1533 year: (1999) ident: 2023041303174552000_26.15.4118.10 publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0702693 – ident: 2023041303174552000_26.15.4118.20 doi: 10.1677/joe.1.05654 – volume: 243 start-page: 397 year: (1987) ident: 2023041303174552000_26.15.4118.39 publication-title: J Pharmacol Exp Ther – ident: 2023041303174552000_26.15.4118.17 doi: 10.1016/S0896-6273(01)00517-7 – volume: 22 start-page: 5769 year: (2002) ident: 2023041303174552000_26.15.4118.1 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.22-13-05769.2002 – ident: 2023041303174552000_26.15.4118.11 doi: 10.1038/sj.bjp.0702922 – ident: 2023041303174552000_26.15.4118.5 doi: 10.1074/jbc.273.50.33174 – ident: 2023041303174552000_26.15.4118.7 doi: 10.1073/pnas.072075399 – ident: 2023041303174552000_26.15.4118.12 doi: 10.1038/sj.bjp.0705781 – volume: 54 start-page: 704 year: (1998) ident: 2023041303174552000_26.15.4118.26 publication-title: Mol Pharmacol doi: 10.1016/S0026-895X(24)13072-6 – volume: 81 start-page: 299 year: (2001) ident: 2023041303174552000_26.15.4118.40 publication-title: Physiol Rev doi: 10.1152/physrev.2001.81.1.299 – ident: 2023041303174552000_26.15.4118.15 doi: 10.1124/mol.105.013185 – volume: 18 start-page: 4588 year: (1998) ident: 2023041303174552000_26.15.4118.34 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.18-12-04588.1998 – ident: 2023041303174552000_26.15.4118.14 doi: 10.1523/JNEUROSCI.2499-04.2004 – ident: 2023041303174552000_26.15.4118.25 doi: 10.1124/mol.104.004994 – volume: 289 start-page: 607 year: (1999) ident: 2023041303174552000_26.15.4118.27 publication-title: J Pharm Exp Ther doi: 10.1016/S0022-3565(24)38179-0 – volume: 6 start-page: 3229 year: (1986) ident: 2023041303174552000_26.15.4118.29 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.06-11-03229.1986 – ident: 2023041303174552000_26.15.4118.8 doi: 10.1074/jbc.M300525200 – ident: 2023041303174552000_26.15.4118.41 doi: 10.1074/jbc.M204136200 – ident: 2023041303174552000_26.15.4118.4 doi: 10.1124/mol.104.004747 – ident: 2023041303174552000_26.15.4118.18 doi: 10.1146/annurev.neuro.27.070203.144206 – ident: 2023041303174552000_26.15.4118.24 doi: 10.1210/me.2003-0066 – volume: 58 start-page: 1570 year: (2000) ident: 2023041303174552000_26.15.4118.2 publication-title: Mol Pharmacol doi: 10.1124/mol.58.6.1570 – volume: 53 start-page: 1 year: (2001) ident: 2023041303174552000_26.15.4118.16 publication-title: Pharmacol Rev doi: 10.1016/S0031-6997(24)01478-9 – ident: 2023041303174552000_26.15.4118.28 doi: 10.1002/syn.10014 – ident: 2023041303174552000_26.15.4118.36 doi: 10.1016/S0959-4388(03)00069-2 – ident: 2023041303174552000_26.15.4118.21 doi: 10.1124/mol.52.1.136 – ident: 2023041303174552000_26.15.4118.32 doi: 10.1186/1475-925X-2-13 – ident: 2023041303174552000_26.15.4118.6 doi: 10.1124/jpet.102.040378 – volume: 12 start-page: 433 year: (1994) ident: 2023041303174552000_26.15.4118.22 publication-title: Neuron doi: 10.1016/0896-6273(94)90283-6 – volume: 26 start-page: 489 year: (1984) ident: 2023041303174552000_26.15.4118.38 publication-title: Mol Pharmacol – ident: 2023041303174552000_26.15.4118.9 doi: 10.1124/mol.65.3.528 – ident: 2023041303174552000_26.15.4118.19 doi: 10.1523/JNEUROSCI.5045-04.2005 – ident: 2023041303174552000_26.15.4118.30 doi: 10.1046/j.1471-4159.2002.00972.x – ident: 2023041303174552000_26.15.4118.3 doi: 10.1016/j.coph.2004.08.012 – volume: 47 start-page: 666 year: (1995) ident: 2023041303174552000_26.15.4118.31 publication-title: Mol Pharmacol – ident: 2023041303174552000_26.15.4118.23 doi: 10.1074/jbc.271.32.19021 – ident: 2023041303174552000_26.15.4118.33 doi: 10.1073/pnas.111152398 – ident: 2023041303174552000_26.15.4118.13 doi: 10.1016/j.conb.2004.05.005 – volume: 22 start-page: 4328 year: (2002) ident: 2023041303174552000_26.15.4118.35 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.22-11-04328.2002 – ident: 2023041303174552000_26.15.4118.37 doi: 10.1016/S0896-6273(01)80032-5 |
SSID | ssj0007017 |
Score | 2.124178 |
Snippet | A close relationship between desensitization and internalization of μ-opioid receptors (MORs) has been proposed based on differential actions of series of... A close relationship between desensitization and internalization of mu-opioid receptors (MORs) has been proposed based on differential actions of series of... A close relationship between desensitization and internalization of mu -opioid receptors (MORs) has been proposed based on differential actions of series of... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 4118 |
SubjectTerms | Animals Brain - physiology Cell Culture Techniques Genes, Reporter Green Fluorescent Proteins - analysis Green Fluorescent Proteins - genetics Locus Coeruleus - physiology Mice Mice, Transgenic Neurons - cytology Neurons - physiology Receptors, Opioid, mu - physiology |
Title | Separation of μ-Opioid Receptor Desensitization and Internalization: Endogenous Receptors in Primary Neuronal Cultures |
URI | https://www.ncbi.nlm.nih.gov/pubmed/16611829 https://www.proquest.com/docview/17117513 https://www.proquest.com/docview/67864594 https://pubmed.ncbi.nlm.nih.gov/PMC6673897 |
Volume | 26 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lc9MwENZkyoULA5RHeOpAuTBO_ZAtm1vJhAntUGDSzvTmkWW5mFC7k9jDpL-N39DfxOrhR9LyKBdPolhK5P2yu5J2v0XoVZDZjPPQszjngUWE8K0ozIjFoyT1KBgYN5GJwh8Pg-kx2T_xTwaDy17UUl0lI35xbV7J_0gV2kCuMkv2BpJtB4UGeA3yhStIGK7_JOOZ0Mzd2ufbGU923o2tT-d5mcukQxmwUi5AoyxlkHplEi5NALDmfjZtcltgUqSlIWxtuqpQ2c-GjkKxeEjXVZNwmtDDbx3Yeq5tjySzh6iqYmesOJ3Xatd5JubLfJF3u9wLybMBoDQZRHlrLw5A5axkzScd_XFRV2W7NTxnqnT4m2meilU9zzc3MSRbYk_XuRRWsUQX7BkJo4tddfjj9JW1Tq9vQOn3VC9xjCIX5q1OqL5iInxFVbF_KCMlZ-MPI9Bysr6FOoXqjGITCLBhK9sIRrl2gpHidpxYjhPbQawZ4G-5NAhkRY2DLx17PbVVBeh2siZjHcbZvf73rDtLV1ZAm4G8Pc_o6C66Y-SO9zQ-76GBKO6j7b2CVeXZCr_GKshYnd5sox8dZHGZ4cufBq64wRzegCsGuOINuL7FHVjbjkucF9iAFTdgxQ1YH6Dj95Oj8dQytT8sTohXWcQXaQKrkSixg9TJkowxIg2SFzk0TNyAuRlPqA_rl0hWhPA5C10GTzhjNI0E87yHaKsoC_EYYUEYtZmdMZGA-wwdSMhSzqE589IsDIbIbx5yzA0xvqzP8j3-s5CHaLftd66n99ceLxsZxqDF5dEcKwQ8q9ihkjLX8X5_BziVkveJDNEjLfPuO8HFdkI3GiK6hob2Bskgv_5JkX9VTPKq5m9En9x4Jk_R7e5v_AxtVYtaPAfvvEpeKMj_AtIb6VE |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Separation+of+%CE%BC-Opioid+Receptor+Desensitization+and+Internalization%3A+Endogenous+Receptors+in+Primary+Neuronal+Cultures&rft.jtitle=The+Journal+of+neuroscience&rft.au=Arttamangkul%2C+Seksiri&rft.au=Torrecilla%2C+Maria&rft.au=Kobayashi%2C+Kazuto&rft.au=Okano%2C+Hideyuki&rft.date=2006-04-12&rft.issn=0270-6474&rft.eissn=1529-2401&rft.volume=26&rft.issue=15&rft.spage=4118&rft.epage=4125&rft_id=info:doi/10.1523%2FJNEUROSCI.0303-06.2006&rft.externalDBID=n%2Fa&rft.externalDocID=10_1523_JNEUROSCI_0303_06_2006 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-6474&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-6474&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-6474&client=summon |